Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Clorox Co-The Market Cap
The Clorox Co-The (CLX) share price is expected to decrease by 2.48% over the next year. This is based on calculating the average 12-month share price estimate provided by 21 stock analysts who have covered CLX. Price targets range from $139 at the low end to $188 at the high end. The current analyst consensus for CLX is a hold. Please note analyst price targets are not guaranteed and could be missed completely.
About 21 Wall Street analysts have assigned CLX 2 buy ratings, 14 hold ratings, and 5 sell ratings. This means that analysts expect Clorox Co-The to generate similar returns as the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on CLX. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of CLX.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Robert Moskow TD Cowen | Hold | $170 | Upgrade | Nov 6, 2024 |
| Linda Bolton Weiser DA Davidson | Neutral | $171 | Maintains | Nov 4, 2024 |
| Lauren Lieberman Barclays | Underweight | $139 | Maintains | Nov 1, 2024 |
| Javier Escalante Evercore ISI Group | Underperform | $139 | Maintains | Oct 14, 2024 |
| Lauren Lieberman Barclays | Underweight | $137 | Maintains | Oct 11, 2024 |
| Andrea Teixeira JP Morgan | Neutral | $174 | Maintains | Oct 11, 2024 |
| Kaumil Gajrawala Jefferies | Buy | $187 | Upgrade | Oct 1, 2024 |
| Linda Bolton Weiser DA Davidson | Neutral | $153 | Maintains | Sep 6, 2024 |
| Wendy Nicholson Citigroup | Neutral | $170 | Maintains | Sep 6, 2024 |
| Wendy Nicholson Citigroup | Neutral | $165 | Maintains | Aug 28, 2024 |
| Lauren Lieberman Barclays | Underweight | $130 | Maintains | Aug 5, 2024 |
| Stephen Powers Deutsche Bank | Hold | $151 | Maintains | Aug 2, 2024 |
| Linda Bolton Weiser DA Davidson | Neutral | $153 | Maintains | Aug 2, 2024 |
| Andrea Teixeira JP Morgan | Neutral | $148 | Maintains | Aug 2, 2024 |
| Robert Moskow TD Cowen | Sell | $122 | Initiates | Jul 23, 2024 |
| Andrea Teixeira JP Morgan | Neutral | $150 | Maintains | Jul 22, 2024 |
| Lauren Lieberman Barclays | Underweight | $122 | Maintains | Jul 19, 2024 |
Citigroup | Neutral | Maintains | Jul 11, 2024 | |
| Chris Carey Wells Fargo | Underweight | $130 | Maintains | Jul 10, 2024 |
| Wendy Nicholson Citigroup | Neutral | $145 | Maintains | Jul 10, 2024 |
When did it IPO
1983
Staff Count
7,400
Country
United States
Sector/Industry
Consumer Defensive/Household & Personal Products
CEO
Ms. Linda Rendle
Market Cap
$20.72B
In 2023, CLX generated $7.39B in revenue, which was a increase of 3.97% from the previous year. This can be seen as a signal that CLX's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Mon, 09 Dec 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Clorox (CLX) has received a Zacks Rank #2 (Buy) upgrade, indicating increased optimism about its earnings prospects, which may boost the stock price in the near term.
Why It Matters - Clorox's upgrade to a Zacks Rank #2 suggests increased confidence in its earnings potential, likely leading to higher stock demand and potential price appreciation.
Sat, 07 Dec 2024
Sentiment - POSITIVE
Source - Seeking Alpha
Summary - In 2024, the S&P has risen nearly 28%. Investors anticipate a potential correction in 2025. Dividend Aristocrats may offer stability with a 3.2% yield and lower volatility than the S&P.
Why It Matters - Rising S&P gains raise concerns of a market correction. Dividend Aristocrats present a safer investment with attractive yields and lower volatility, appealing during uncertain times.
Wed, 04 Dec 2024
Sentiment - POSITIVE
Source - The Motley Fool
Summary - Investors favor safe dividend stocks for passive income and reduced volatility, but even conservative companies can outperform the market.
Why It Matters - The excerpt highlights that even traditionally stable dividend stocks can outperform the market, suggesting potential for unexpected gains in seemingly safe investments.
Mon, 02 Dec 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - CLX is experiencing advantages from strong pricing and cost-saving measures, with its IGNITE strategy expected to further enhance performance.
Why It Matters - CLX's strong pricing and cost-saving measures enhance profitability, while the IGNITE strategy suggests potential for future growth, positively impacting investor confidence and stock performance.
Tue, 03 Dec 2024
Sentiment - POSITIVE
Source - The Motley Fool
Summary - Investors are advised to review their portfolios and update watch lists as stock market indexes approach all-time highs, making it challenging to find quality stocks at lower prices.
Why It Matters - The need for a portfolio review signals potential market corrections. High indexes suggest overvaluation risks, prompting cautious stock selection for better long-term returns.
Fri, 29 Nov 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Clorox (CLX) recently reported earnings. Investors should monitor upcoming developments and market reactions for potential impacts on the stock.
Why It Matters - Clorox's recent earnings report can influence stock performance, affecting investor sentiment, potential dividends, and market positioning. Upcoming analysis may impact trading strategies.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
